Noopept and Oxiracetam Interaction

Compatible
Researched 90% confidence

Noopept and Oxiracetam have a compatible interaction with 90% confidence. Oxiracetam and Noopept operate through overlapping but distinct mechanisms. Oxiracetam primarily modulates AMPA receptors and cholinergic signaling, while Noopept additionally modulates NMDA receptors and upregulates BDNF and NGF. The combination is well tolerated and commonly used in nootropic stacks. Use standard doses of each, as there is no known pharmacokinetic interaction. Both compounds affect the brain, so monitoring these systems is recommended.

Compound Profiles

Noopept

Nootropic Peptide | Memory & Neuroprotection

Noopept exerts its nootropic and neuroprotective effects through several interconnected mechanisms. It modulates glutamatergic neurotransmission by acting as a positive modulator at AMPA and NMDA receptors, enhancing long-term potentiation (LTP) in the hippocampus -- the core cellular process underlying memory formation.

Half-life: ~30 minutes (oral), active metabolite cycloprolylglycine persists longer Typical dose: 10-30 mg/day cognitive
bdnfngf blood pressure raisingcrosses bbbteratogenic
View full profile

Oxiracetam

Racetam Nootropic | Logic, Processing Speed & Technical Work

Oxiracetam enhances cognitive function primarily through positive allosteric modulation of AMPA-type glutamate receptors, increasing the excitatory postsynaptic response to glutamate and facilitating long-term potentiation (LTP) in hippocampal and cortical circuits. This AMPA modulation is thought to underlie its effects on memory encoding and retrieval.

Half-life: ~8 hours Typical dose: 800-1600 mg/day cognitive
epo receptor teratogenic
View full profile

Combined Organ Load

Brain
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Noopept, Oxiracetam). Monitor accordingly.

Frequently Asked Questions

Can I take Noopept with Oxiracetam?

Yes, Noopept and Oxiracetam can generally be taken together. Oxiracetam and Noopept operate through overlapping but distinct mechanisms. Oxiracetam primarily modulates AMPA receptors and cholinergic signaling, while Noopept additionally modulates NMDA receptors and upregulates BDNF and NGF. The combination is well tolerated and commonly used in nootropic stacks. Use standard doses of each, as there is no known pharmacokinetic interaction.

Is Noopept and Oxiracetam safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Noopept and Oxiracetam?

Oxiracetam and Noopept operate through overlapping but distinct mechanisms. Oxiracetam primarily modulates AMPA receptors and cholinergic signaling, while Noopept additionally modulates NMDA receptors and upregulates BDNF and NGF. The combination is well tolerated and commonly used in nootropic stacks. Use standard doses of each, as there is no known pharmacokinetic interaction. This assessment has 90% confidence and is based on documented research data.

How should I time Noopept and Oxiracetam?

Noopept has a half-life of ~30 minutes (oral), active metabolite cycloprolylglycine persists longer and Oxiracetam has a half-life of ~8 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Noopept vs Oxiracetam

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.